1. Home
  2. AIR vs AMRX Comparison

AIR vs AMRX Comparison

Compare AIR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAR Corp.

AIR

AAR Corp.

N/A

Current Price

$115.92

Market Cap

5.8B

Sector

Industrials

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$16.65

Market Cap

6.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIR
AMRX
Founded
1951
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.2B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
AIR
AMRX
Price
$115.92
$16.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$131.20
$15.60
AVG Volume (30 Days)
326.7K
1.4M
Earning Date
03-24-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
1288.57
157.89
EPS
4.86
0.37
Revenue
N/A
N/A
Revenue This Year
$18.83
$4.48
Revenue Next Year
$10.93
$7.13
P/E Ratio
$25.82
$45.97
Revenue Growth
N/A
N/A
52 Week Low
$74.24
$9.49
52 Week High
$154.00
$19.26

Technical Indicators

Market Signals
Indicator
AIR
AMRX
Relative Strength Index (RSI) 35.99 44.87
Support Level $101.48 $16.61
Resistance Level $121.05 $18.19
Average True Range (ATR) 4.18 0.45
MACD -1.04 -0.10
Stochastic Oscillator 0.72 30.82

Price Performance

Historical Comparison
AIR
AMRX

About AIR AAR Corp.

AAR Corp offers a broad line of products and services to commercial and government aerospace customers and operates internationally. It is a diversified provider of services and products to the commercial aviation and government and defense markets, serving aircraft fleet operators, original equipment manufacturers, independent service providers, and domestic and foreign military customers. It operates through the Parts Supply, Repair, Engineering and Software, Government Solutions, and Legacy Commercial Programs segments. The Parts Supply segment mainly consists of new parts distribution and sales of used serviceable material, including aircraft, engine, and airframe parts and components (USM), and generates the maximum revenue. It generates the maximum revenue from North America.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: